Cigarette Smoking Decreases Global MicroRNA Expression in Human Alveolar Macrophages

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Graff, Joel W ^a,b   Powers, Linda S ^a   Dickson, Anne M ^a,d   Kim, Jongkwang ^a   Reisetter, Anna C ^a   Hassan, Ihab H ^a   Kremens, Karol ^a   Gross, Thomas J ^a   Wilson, Mary E ^a,b,c   Monick, Martha M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Life Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 452; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; DATABASES, GENETIC; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MATRIX METALLOPROTEINASE 12; MICRORNAS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SMOKING; TISSUE DONORS; UP-REGULATION;

EID: 84865597141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044066     Document Type: Article

References (66)

1. Heguy A, O'Connor TP, Luettich K, Worgall S, Cieciuch A, et al. (2006) Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med 84: 318-328.
2. Shaykhiev R, Krause A, Salit J, Strulovici-Barel Y, Harvey BG, et al. (2009) Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 183: 2867-2883.
3. Vlahos R, Bozinovski S, Jones JE, Powell J, Gras J, et al. (2006) Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 290: L931-945.
4. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653.
5. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG, (1995) Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 152: 1666-1672.
6. Barnes PJ, Shapiro SD, Pauwels RA, (2003) Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22: 672-688.
7. Shapiro SD, (1999) The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: S29-32.
8. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD, (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004.
9. Shapiro SD, (2005) COPD unwound. N Engl J Med 352: 2016-2019.
10. Shapiro SD, Ingenito EP, (2005) The Pathogenesis of Chronic Obstructive Pulmonary Disease: Advances in the Past 100 Years. Am J Respir Cell Mol Biol 32: 367-372.
11. Hunninghake GM, Cho MH, Tesfaigzi Y, Soto-Quiros ME, Avila L, et al. (2009) MMP12, lung function, and COPD in high-risk populations. N Engl J Med 361: 2599-2608.
12. Bitterman PB, Rennard SI, Hunninghake GW, Crystal RG, (1982) Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest 70: 806-822.
13. Bitterman PB, Wewers MD, Rennard SI, Adelberg S, Crystal RG, (1986) Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest 77: 700-708.
14. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, et al. (2006) Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 116: 753-759.
15. Venet A, Hance AJ, Saltini C, Robinson BW, Crystal RG, (1985) Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis. J Clin Invest 75: 293-301.
16. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, et al. (2000) Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A 97: 5972-5977.
17. Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S, (2006) Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis 194: 1375-1384.
18. Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE, (2007) Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol 179: 6097-6106.
19. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, et al. (2007) Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. American journal of respiratory cell and molecular biology 37: 748-755.
20. King TE Jr, Savici D, Campbell PA, (1988) Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis 158: 1309-1316.
21. Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, et al. (2002) Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 283: L867-873.
22. Stampfli MR, Anderson GP, (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9: 377-384.
23. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nature Rev Immunol 8: 958-969.
24. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555.
25. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, et al. (2005) A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 172: 1383-1392.
26. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
27. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591.
28. Guo H, Ingolia NT, Weissman JS, Bartel DP, (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
29. Djuranovic S, Nahvi A, Green R, (2011) A parsimonious model for gene regulation by miRNAs. Science 331: 550-553.
30. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
31. Taganov KD, Boldin MP, Chang KJ, Baltimore D, (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103: 12481-12486.
32. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, et al. (2009) The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31: 220-231.
33. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D, (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104: 1604-1609.
34. Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, et al. (2009) LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 23: 2898-2908.
35. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, et al. (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089.
36. Tserel L, Runnel T, Kisand K, Pihlap M, Bakhoff L, et al. (2011) MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 286: 26487-26495.
37. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, et al. (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142: 914-929.
38. Nahid MA, Pauley KM, Satoh M, Chan EK, (2009) miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J Biol Chem 284: 34590-34599.
39. O'Neill LA, Sheedy FJ, McCoy CE, (2011) MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 11: 163-175.
40. Tang Y, Luo X, Cui H, Ni X, Yuan M, et al. (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60: 1065-1075.
41. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, et al. (2009) MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A 106: 2319-2324.
42. Reisetter AC, Stebounova LV, Baltrusaitis J, Powers L, Gupta A, et al. (2011) Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J Biol Chem 286: 21844-21852.
43. Monick MM, Carter AB, Gudmundsson G, Geist LJ, Hunninghake GW, (1998) Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes. Am J Physiol 275: L389-397.
44. Monick MM, Powers LS, Barrett CW, Hinde S, Ashare A, et al. (2008) Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity. J Immunol 180: 7485-7496.
45. Monick MM, Powers LS, Gross TJ, Flaherty DM, Barrett CW, et al. (2006) Active ERK Contributes to Protein Translation by Preventing JNK-Dependent Inhibition of Protein Phosphatase 1. J Immunol 177: 1636-1645.
46. Monick MM, Powers LS, Walters K, Lovan N, Zhang M, et al. (2010) Identification of an autophagy defect in smokers' alveolar macrophages. J Immunol 185: 5425-5435.
47. Benjamini Y, Krieger A, Yekutieli D (2001) Two staged linear step up FDR controlling procedure. Tel Aviv University, and Department of Statistics, Wharton School, University of Pennsylvania.
48. Langfelder P, Horvath S, (2007) Eigengene networks for studying the relationships between co-expression modules. BMC systems biology 1: 54.
49. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
50. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
51. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, et al. (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42: 1530-1536.
52. Hansdottir S, Monick MM, (2011) Vitamin D effects on lung immunity and respiratory diseases. Vitamins and hormones 86: 217-237.
53. Martinez FO, Gordon S, Locati M, Mantovani A, (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. Journal of immunology 177: 7303-7311.
54. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, et al. (2009) Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 23: 806-812.
55. Martinez FO, Sica A, Mantovani A, Locati M, (2008) Macrophage activation and polarization. Frontiers in bioscience: a journal and virtual library 13: 453-461.
56. Stampfli MR, Anderson GP, (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nature reviews Immunology 9: 377-384.
57. Modestou MA, Manzel LJ, El-Mahdy S, Look DC, (2010) Inhibition of IFN-gamma-dependent antiviral airway epithelial defense by cigarette smoke. Respir Res 11: 64.
58. Dhillon NK, Murphy WJ, Filla MB, Crespo AJ, Latham HA, et al. (2009) Down modulation of IFN-gamma signaling in alveolar macrophages isolated from smokers. Toxicol Appl Pharmacol 237: 22-28.
59. Pottelberge GR, Mestdagh P, Bracke KR, Thas O, Durme YM, et al. (2011) MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183: 898-906.
60. D'Hulst A I, Bracke KR, Maes T, De Bleecker JL, Pauwels RA, et al. (2006) Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 28: 102-112.
61. Gao C, Guo H, Mi Z, Grusby MJ, Kuo PC, (2007) Osteopontin induces ubiquitin-dependent degradation of STAT1 in RAW264.7 murine macrophages. Journal of immunology 178: 1870-1881.
62. Guo H, Wai PY, Mi Z, Gao C, Zhang J, et al. (2008) Osteopontin mediates Stat1 degradation to inhibit iNOS transcription in a cecal ligation and puncture model of sepsis. Surgery 144: 182-188.
63. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468.
64. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
65. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, et al. (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes & development 20: 2202-2207.
66. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T, (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677.